AVGR logo

Avinger, Inc. Stock Price

NasdaqCM:AVGR Community·US$1.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

AVGR Share Price Performance

US$0.47
-0.33 (-40.98%)
US$0.47
-0.33 (-40.98%)
Price US$0.47

AVGR Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate with mediocre balance sheet.

5 Risks
2 Rewards

Avinger, Inc. Key Details

US$7.3m

Revenue

US$5.7m

Cost of Revenue

US$1.5m

Gross Profit

US$18.9m

Other Expenses

-US$17.4m

Earnings

Last Reported Earnings
Sep 30, 2024
Next Reporting Earnings
n/a
-5.43
20.94%
-238.96%
107.6%
View Full Analysis

About AVGR

Founded
2007
Employees
70
CEO
n/a
WebsiteView website
avinger.com

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.

Recent AVGR News & Updates

Recent updates

No updates